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Plasma creatine kinase indicates major amputation
or limb preservation in acute lower limb ischemia
Ian S. Currie, BSc, MBChB, MD, PhD,a Sonia J. Wakelin, BSc, MBChB, PhD,a Amanda J. Lee, BSc, PhD,b
and Roderick T. Chalmers, MBChB, MD,a Edinburgh and Aberdeen, United Kingdom
Objective: Acutely ischemic limbs are often of uncertain viability. To assist operative management, this study determined
prospectively which indicators on admission were the best predictors of major amputation and, conversely, limb
preservation.
Methods: Data were collected on admission. Presenting complaint, history, clinical assessment, and blood test results,
including creatine kinase (CK), were recorded. Surgical procedures were noted—in particular, the presence or absence of
major amputation by death or discharge. The setting was a tertiary vascular referral center in a university teaching
hospital. Subjects included all patients referred as emergency cases to the vascular unit over an 18-month period who were
admitted for inpatient management with acute lower limb ischemia. The main outcome measure was major amputation.
Results: A total of 97 patients with acute ischemia were studied prospectively (51 men and 46 women). Twenty-one
patients (21.6%) underwent major amputation. Previous vascular surgery (P  .012), mottling (P  .001), sensory loss
(P  .003), motor loss (P  .001), muscle tenderness (P < .001), absent ankle Doppler signals (P  .008), neutrophilia
(P .011), and increased CK (P< .001) were significantly associated with major amputation. If CK was normal, the risk
of major amputation was 4.6% (95% confidence interval, 0.0%-9.7%). If CK was increased, the risk was 56.2% (95% CI,
39.1%-73.4%).
Conclusions: Specific clinical findings were significantly associated with major amputation. Of these, only CK had a
positive predictive value greater than 50%. Plasma CK can assist operative management of acute lower limb ischemia by
quantifying prospectively the risk of major amputation or limb preservation on admission. (J Vasc Surg 2007;45:733-9.)Appropriate management of acute lower limb ischemia
is complicated by a lack of robust clinical indicators that are
accurately predictive of outcome. A history of two or more
myocardial infarctions, chronic limb ischemia, or pro-
longed ischemic symptoms is associated with an increased
risk of amputation within 30 days in patients presenting
after an acute ischemic event.1 Absent ankle Doppler sig-
nals or the presence of a neurosensory deficit is also signif-
icantly associated with limb loss over this time period.2
Increases in plasma creatine kinase (CK) have been de-
tected in femoral venous efflux from ischemic limbs,3 and
patients undergoing amputation for severe ischemia have
been noted to have increased CK before surgery.4 How-
ever, no study has addressed the predictive value of normal
or increased CK in acute limb ischemia. To investigate such
prognostic markers, this study hypothesized that plasma
CK on admission would be predictive of major amputation
in acute lower limb ischemia. This prospective investigation
collected clinical and laboratory data, including CK levels,
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METHODS
Data were collected prospectively over an 18-month
period from 102 patients with signs and symptoms of acute
lower limb ischemia admitted as emergency cases to the
Department of Vascular Surgery, Royal Infirmary of Edin-
burgh, United Kingdom.
Study design. Data were collected on admission. The
duration of symptoms and history of risk factors, as well as
specific disorders that would compromise the interpreta-
tion of blood tests, were recorded. An electrocardiogram,
neutrophil count, urea, creatinine, bicarbonate, and CK
level were obtained on all patients as a matter of routine.
Interventions were recorded in addition to subsequent
outcomes, in particular the presence or absence of major
amputation. All management decisions were made by the
admitting consultant after clinical assessment. The con-
sultant had access to standard blood results but no access
to CK.
Inclusion criteria. All patients admitted as emergency
cases to the vascular unit with new or newly increased
symptoms of lower limb ischemia arising over the preced-
ing 7 days were included in the study. To ensure that the
data reflected the breadth of patients presenting with isch-
emic symptoms, all patients, regardless of severity, were
included. The term acute ischemia is therefore used in the
broadest sense throughout this article and includes patients
with mild and severe ischemia.
Exclusion criteria. Known unreconstructable disease
at the time of admission served to exclude data from
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ease, acute myocardial infarction, acute stroke, musculo-
skeletal trauma, or abdominal pain, all of which could
substantially alter the interpretation of tests used in this
study, were excluded. Patients who were clearly moribund
and beyond operative intervention were also excluded.
Second and subsequent presentations of the same patient
within the study period were also excluded. In each case,
these exclusions prevented false correlations between clin-
ical assessments, blood tests, and outcomes.
Data analysis. SPSS version 12.0 (SPSS Inc, Chicago,
Ill) was used for all statistical analyses. Associations between
categorical variables were examined by using the 2 test or
Fisher’s exact test, where appropriate. Receiver operator
characteristic (ROC) curves were produced to investigate
the predictive utility of CK on admission. Asymptotic P
values for the ROC curves were calculated under the non-
parametric Wilcoxon statistic assumption.5 Positive predic-
tive values and false-negative rates for different thresholds
of CK were also calculated by standard techniques.
During analysis, no attempt was made to stratify pa-
tients into mildly or severely ischemic groups. This ap-
proach permitted the most robust comparisons to be made.
For example, the disproportionate increase in limb loss in
the presence of a specific risk factor could be demonstrated
only by the inclusion of the related group in which the
absence of the risk factor was associated with dispropor-
tionate limb preservation.
RESULTS
Study patients and exclusions. Over the study pe-
riod, 102 patients presented as emergency cases with new
symptoms that had occurred during the week before admis-
sion. Two patients were excluded after acute myocardial
infarction or stroke was diagnosed. This rendered impossi-
ble the interpretation of CK results and potentially altered
the operative strategy. Three further patients were excluded
as a result of advanced limb ischemia with multiorgan
failure. No surgery could be contemplated in these patients.
Of the remaining 97 patients, 73 required operative inter-
vention, of whom 60 required limb salvage surgery and 13
underwent primary amputation. Eight underwent second-
ary amputation. Twenty-five patients (34.2%) were oper-
ated on within 24 hours of admission, and a further 20
(27.4%), within the next 24 hours.
Demographics. Table I shows that there was no sig-
nificant difference in the proportion of men and women
(P .258) and no significant difference between the ages at
which men and women presented (P .396). Male sex was
not a predictor of amputation (P  .334).
Inpatient course. The inpatient course for the entire
cohort (n  97) is shown in Table II. Twenty-four patients
did not undergo operative intervention, and 17 of these
required anticoagulation alone. One was found to have no
surgical option after investigation and rapidly died. A sec-
ond died after amputation was declined. A third required
angioplasty. The remaining 21 patients were discharged
after full vascular investigation and conservative manage-ment. Fifteen of twenty-four had one or more clinical signs
associated with an increased amputation risk (Table III).
The mean CK (log10 transformed to correct for asymme-
try) in this group was 0.48 times the upper limit of normal
(95% confidence interval [CI], 0.074-3.09), with a range of
0.13 to 5.81 times normal. Of the remainder, 73 required
surgery, of which 21 required primary (n 13) or second-
ary (n  8) amputation.
Table IV shows a more detailed description for the
21 patients who underwent major amputation. Thirteen
(61.9%) of 21 underwent primary amputation, whereas 8
(38.1%) of 21 underwent amputation after attempted limb
salvage. The mean CK of those undergoing primary ampu-
tation was 4.29 times the upper limit of normal (95% CI,
0.46-39.8). Of the eight patients who underwent second-
ary amputation, three had normal CK on admission. One
patient presented with acute embolism, received anticoag-
ulation therapy, and developed heparin-induced thrombo-
cytopenia with massive arterial thrombosis. Despite opera-
tive intervention, the patient required amputation. A
second patient with embolism showed marked cardiorespi-
ratory instability during embolectomy. This patient re-
Table I. Study demographics (n  97)
Variable Data
Sex
Male 51
Female 46
Age (y)
Men 68 (63-77)
Women 73.5 (56-80)
Symptom duration (d) 1 (0-4)
Previous vascular surgery 20
Bypass graft 14
Acute graft blockage 9
Exclusions (n  5)
Moribund 3
Acute myocardial infarction 1
Acute stroke 1
Data are n or median (interquartile range).
Table II. Inpatient course
Variable n (%)
No surgical intervention 24 (24.7)
Anticoagulation 17 (17.5)
Angioplasty 1 (1.0)
Surgical intervention 73 (75.3)
Thromboembolectomy  lysis 41 (42.3)
Revascularization 19 (19.6)
Major amputation (1° and 2°) 21 (21.6)
Deaths in vascular unit 5 (5.2)
Major amputation 3
Amputation planned, consent withheld 1
Disseminated malignancy 1
A total of 81 operations are shown for 73 patients, because 8 patients
underwent secondary amputation.quired a secondary amputation when sufficiently recovered.
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during coronary angiography and underwent laparotomy
and bilateral femoral embolectomy with thrombolysis.
However, one foot progressively developed irreversible
ischemia and necessitated below-knee amputation on day 11.
Of the remaining five patients who had secondary
amputation, all had abnormal CK and underwent initial
limb salvage surgery. One of the 2 with CK greater than 10
times normal underwent emergency revascularization fol-
lowed by secondary amputation within 24 hours. The other
Table III. Clinical assessment in acute limb ischemia
Variable n (%)
Amputation,
n (%)
P
value
Presenting complaint
Cold limb 53 (54.6) 12/53 (22.6) .795
Pain 89 (91.7) 21/89 (23.6) .195
Numbness 49 (50.5) 13/49 (26.5) .238
Weakness 23 (23.7) 6/23 (26.1) .560
New claudication 22 (22.7) 1/22 (4.5) .064
History
Smoking 46 (47.4) 9/46 (19.6) .563
Diabetes 16 (16.5) 2/16 (12.5) .509
Ischemic heart disease 34 (35.1) 8/34 (23.5) .772
Hypercholesterolemia 19 (19.6) 7/19 (36.8) .120
Hypertension 39 (40.2) 8/39 (20.5) .789
Previous vascular
surgery 20 (20.6) 9/20 (45) .012
Clinical findings
Cool limb 65 (67.0) 16/65 (24.6) .433
Reduced capillary refill 44 (45.4) 6/44 (13.6) .081
Absent foot pulses 83 (85.6) 17/83 (20.5) .339
Absent ankle Doppler 57 (68.7) 17/57 (29.8) .008
Mottling 38 (39.2) 15/38 (39.5) .001
Muscle tenderness 31 (32.0) 14/31 (45.2) .001
Motor loss 31 (32.0) 13/31 (41.9) .001
Sensory loss 51 (52.6) 17/51 (33.3) .003
The number and percentage demonstrating pathologic findings is shown,
along with the number of patients (%) demonstrating the abnormality who
underwent amputation. The P value (from 2 or Fisher’s exact tests)
demonstrates the relationship with amputation.
Table IV. Management before major amputation
(n  21)
Variable n (%)
Immediate management
Anticoagulation 8 (38.1)
Imaging 8 (38.1)
Diagnosis
Embolism 3 (14.3)
Thrombosis in situ 12 (57.1)
Graft occlusion 6 (28.6)
Operative strategy
Thromboembolectomy  on-table lysis 5 (23.8)
Formal revascularization 3 (14.3)
Primary amputation 13 (61.9)
Secondary amputation 8 (38.1)
Primary interventions for patients who underwent secondary amputation
(n  8) are shown under operative strategy.underwent urgent limb salvage surgery but was foundunexpectedly to have dead muscles and so underwent am-
putation directly. A third patient, with CK 7.78 times the
upper level of normal, also underwent exploratory surgery
before amputation under the same anesthetic. The remain-
ing two patients had admission CK levels 4.18 and 1.67
times normal. These patients had embolectomy and fas-
ciotomies or thrombectomy of an acutely occluded com-
mon femoral aneurysm, respectively, but ultimately re-
quired above-knee amputations for irreversible ischemia.
History and examination. Table III demonstrates
that no specific presenting complaint was significantly asso-
ciated with amputation in acute limb ischemia. It is notable
that new-onset claudication (P  .064) attained near-
significance as a predictor of limb preservation. Previous
vascular surgery was identified as significantly associated
with amputation (P  .012). Mottling (P  .001), muscle
tenderness (P .001), motor loss (P .001), and sensory
loss (P  .003) were significantly associated with amputa-
tion. Absent ankle Doppler signals were also significantly
associated with amputation (P  .008); however, it is
important to note that the dataset for ankle Doppler signals
was only partially complete (83/97 patients). Where
Doppler data were not recorded before treatment, this
reflected the urgency with which patients presenting with
severe acute ischemia were treated by heparinization, an-
giography, and/or surgery. Three (21.4%) of 14 patients
who did not have admission Doppler pressures recorded
subsequently underwent amputation, compared with 18
(21.7%) of 83 whose admission Doppler pressures were
recorded, thus implying no obvious selection bias. The
presence of one or more clinical signs as identified here was
associated with an amputation risk of 25.9% (95% CI,
16.4%-35.4%).
Blood tests. Abnormal CK levels (P  .001) and
neutrophilia (P .011), but not abnormal urea (P .259),
creatinine (P  .354), or bicarbonate (P  .887), on
admission were significantly associated with amputation.
Linear regression analysis confirmed that, in either the
amputation or no-amputation group or in the entire co-
hort, no significant linear relationship existed between the
duration of symptoms and CK levels on admission (P 
.623, .582, and .405 for the three models, respectively).
These data are demonstrated in Fig 1. When data were
restricted to patients with muscle tenderness, there was still
no significant relationship (P  .549).
Predictive factors in major amputation. Table V
shows the factors identified in this study to have a signifi-
cant relationship with amputation. CK demonstrates by far
the strongest statistical relationship. To address the issue of
confounding variables, patients presenting with graft occlu-
sion who underwent primary amputation, all of whom had
increased CK on admission (n  6), were removed from
analysis. There was still a highly significant relationship
between admission CK and amputation (2  23.3; P 
.001). If the patients undergoing primary amputation were
excluded from the dataset, there was still a very strong
relationship between increased CK and amputation (2 
10.897; P .003). The presence of one or more significant
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with an amputation risk of 25.9% (95% CI, 16.4%-35.4%),
whereas increased CK implied a risk of 56.3% (95% CI,
39.1%-73.5%).
Predictive testing using CK. ROC curves were con-
structed for CK. This approach was not possible for the
categorical prognostic factors. CK levels were expressed as a
proportion of the upper limit of normal, because the nor-
mal ranges were different in men and women (200 and 150
U/L, respectively). Figure 2 shows that there was an ex-
ceptionally strong relationship between CK and amputa-
tion. The area under the curve for CK was 0.87 (95% CI,
0.78-0.97). These data show that a higher level of CK is
associated with a higher risk of amputation.
Utility of CK as a clinical test. Having established
that increased CK was associated with an increased occur-
rence of major amputation, positive predictive values were
calculated by using a number of thresholds at which the test
result was considered indicative of irretrievable ischemia. A
range of empirical thresholds was chosen because there are
no established levels. Figure 3 shows that the likelihood of
the tests being correct (true-positive rate) in predicting
major amputation increased from 56.3% (95% CI, 39.1%-
73.5%), when the threshold corresponded to any result
above the upper limit of normal (n  34), to 100%, when
CK was greater than 10 times the upper limit of normal
(n 5). Conversely, a normal CK result conferred a risk of
major amputation of 4.6% (95% CI, 0.0%-9.7%; n  63).
These data show that the false-positive rate for CK greater
than 10 times the upper limit of normal was 0, and the CI
was also 0. Looking at only the patients who required
surgery, the mean CK (log10 transformed to correct for
Fig 1. Scatterplot of creatine kinase (CK) levels on admission and
amputation. Admission CK is plotted on a log scale according to
the duration of acute symptoms. Linear regression analysis con-
firmed that, in either the amputation or no-amputation group or in
the entire cohort, no significant linear relationship existed between
the duration of symptoms and CK levels on admission (P  .623,
.582, and .405 for the three models, respectively).asymmetry) in patients who did not require amputation was0.47 times the upper limit of normal (95% CI, 0.35-0.63;
n 52), whereas the mean CK level for those who did was
3.92 times normal (95% CI, 2.07-7.43; n  21).
DISCUSSION
This study aimed to identify symptoms, signs, and
laboratory markers on admission that could provide an
accurate prognosis in acute limb ischemia. Clinical signs,
such as mottling, muscle tenderness, motor loss, sensory
loss, and absent ankle Doppler signals were significantly
associated with major amputation. However, none of these
gave a positive predictive value greater than 50%. In con-
trast to the categorical nature of these clinical findings, CK
levels offered the possibility of a continuous numerical
index of amputation risk. The data showed that normal CK
on admission was associated with a low risk of amputation
(5%), whereas increasingly abnormal CK was associated
with an increasing risk of major amputation. Any increase in
CK equated to a risk of greater than 50%, and 5 or 10 times
normal conferred amputation risks of 70% and 100%, re-
spectively. Plasma CK levels on admission may be a useful,
simple, and rapid test to assist operative decision making in
acute limb ischemia.
Studies that have addressed acute limb ischemia have
suffered from the lack of a useful, internationally agreed
definition.6 Because chronic ischemia requires a duration of
2 weeks or more to establish the diagnosis,7 some authors
have opted to define acute ischemia in terms of new symp-
toms arising in a previously stable limb for less than 14
days.8,9 Other groups have opted for a purely clinical
definition.2,10 Although there has been an attempt to stan-
dardize the accepted clinical features of acute limb isch-
emia,11 this was not evidence based. In selecting a time
frame for patients with acute ischemia for this study, 7 days
was chosen. Other authors have reported that more severe
ischemia is likely to present with a shorter history.12 Previ-
ous studies in the Edinburgh Vascular Unit have shown
that patients presenting as emergency cases with new symp-
toms of greater than 7 days’ duration uniformly show
normal CK levels on admission (Authors’ unpublished
observations, 2002). Presumably, evidence of muscle injury
in those with shorter histories reflects the intense pain of
truly severe, acute, limb ischemia, prompting patients to
seek help more urgently.
Historical risk factors. Retrospective studies of acute
limb ischemia have shown a number of significant associa-
tions with major amputation. A history of two or more
myocardial infarctions, chronic limb ischemia, and symp-
toms lasting more than 25 hours were all significantly
associated with limb loss within 30 days of an acute isch-
emic event.1 The data shown here reveal that the only
significant association with amputation in the medical his-
tory was previous vascular surgery, whereas the presence of
peripheral vascular disease or the duration of symptoms did
not confer significant added risk. In the amputation group,
9 of 21 had undergone previous vascular surgery, of whom
6 presented with graft occlusion, all with increased CK.
Patients who have had previous bypass grafting with acute
ociate
n. The
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surgical options. It was therefore expected that a link
between previous vascular surgery and amputation would
be detected in this work. However, this raised the possibil-
ity that the observed relationship between CK and ampu-
tation may arise solely as a result of previous vascular
surgery as a confounding variable. To address this issue, the
statistical analysis was repeated after these six patients had
been removed from the data set. This showed there was still
a highly significant relationship between admission CK and
amputation.
Clinical findings. Prospective investigations have
demonstrated that specific clinical signs are strongly associ-
ated with failure of limb salvage. Neurologic dysfunction
on admission or an absence of ankle Doppler signals halves
30-day limb-salvage rates in patients with acute limb isch-
emia,2 although much of the salvage failure was attributable
to mortality. That study is not strictly comparable with the
Table V. Predictive factors for major amputation
Variable n (%) P value Am
Increased creatine kinase 32 (33.0) .001 1
Muscle tenderness 31 (32.0) .001 1
Vascular surgery 20 (20.6) .012
Motor loss 31 (32.0) .001 1
Mottling 38 (39.2) .001 1
Sensory loss 51 (52.6) .001 1
Neutrophilia 50 (51.5) .011 1
Absent ankle Dopplers 57 (68.7) .008 1
This table shows all the predictive factors identified from the history, examina
The number and percentage with each finding are shown, along with the ass
(%) demonstrating the abnormality who underwent amputation is also give
Fig 2. Receiver operator characteristic curve for plasma creatine
kinase on admission as a test predictive of major amputation. The
curve demonstrates that there is a very strong relationship between
increased plasma creatine kinase (CK) and an increased risk of
amputation (P  .001) and that the higher the plasma CK, the
higher the amputation risk. Sensitivity is the true-positive rate, and
1  specificity is the false-positive rate. CI, Confidence interval.present data, because patients with symptoms present for 6weeks or less were chosen. Nonetheless, the present work
confirms these observations. The data presented here also
demonstrate a significant association between muscle ten-
derness/limb mottling and amputation. Both are indica-
tors of more advanced ischemia compared with neurologic
dysfunction or absent Doppler signals. In clinical practice,
the diagnosis of acute severe limb ischemia in the presence
of muscle tenderness and mottling is likely to present less
prognostic difficulty than other, more subtle, signs. How-
ever, these signs are associated with amputation in only 40%
to 45% of cases, and so even limbs that offer a “full house”
of symptoms and signs may be remediable in more than half
of all cases. The decision whether to transfer such a patient
tion, n (%) 2 Positive predictive value % (95% CI)
(56.25) 33.7 56.3 (39.1-73.5)
(45.2) 14.8 45.2 (27.7-62.7)
(45) 8.1 45.0 (23.9-66.1)
(41.9) 12.1 41.9 (24.5-59.3)
(39.5) 11.4 39.5 (24.0-55.0)
(33.3) 8.7 33.3 (20.4-46.2)
(32) 6.5 32.0 (19.1-44.9)
(29.8) 7.1 29.8 (17.9-41.7)
and simple investigations that were significantly associated with amputation.
d P value, 2 statistic, and positive predictive value. The number of patients
statistical data relate to the association with major amputation.
Fig 3. Creatine kinase (CK) levels as a predictive clinical test in
acute limb ischemia. The data are shown as the true-positive rate
(positive predictive value) with the associated 95% confidence
intervals. The true-positive rate describes the percentage of posi-
tive test results, for example, CK above threshold, that are associ-
ated with amputation. Admission plasma CK was expressed as a
multiple of the upper limit of normal CK for men (200 U/L) or
women (150 U/L) and grouped into arbitrary subgroups, either
below the upper limit of normal (1) or greater than once
(1), twice (2), 5 times (5), or 10 times (10) the
upper limit of normal. The number of patients in each group is
shown. It should be noted that, for each subgroup, all applicable
patients were included, and so any patient whose CK was greater
than 10 times normal would qualify for inclusion in each of the
lesser subgroups. The 95% confidence interval for CK 10
normal was 0, because all patients underwent amputation in this
group.puta
8/32
4/31
9/20
3/31
5/38
7/51
6/50
7/57
tion,to a specialist vascular center for emergency revasculariza-
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originating hospital might be made easier if plasma CK
levels were also available.
Laboratory studies. CK has previously been mea-
sured in three small series of patients with limb ischemia. A
Swedish study of nine patients scheduled electively to un-
dergo major lower limb amputation for chronic ischemia
recorded CK levels of greater than twice normal in four of
the group, of whom three had newly progressive symptoms
at the time of sampling.4 In a group of seven patients
admitted as emergency cases with acute limb ischemia, the
median preoperative CK was 367 U/L (range, 38-1149
U/L), compared with the upper limit of normal of 200
U/L.13 No definition of acute ischemia was included in this
article; however, the descriptions of each patient suggest an
acute presentation for each. In this group of seven patients,
two subsequently had major amputations, a proportion
that generally agrees with the observations made in this
study.
Surprisingly, the data presented here showed no rela-
tionship between the CK level and the duration of symp-
toms, even when the analysis was restricted to those with
muscle tenderness. Presumably, ischemic muscle perfusion
dynamically varies according to intravascular clot propaga-
tion and lysis, thus leading to varying symptoms and plasma
CK levels. Observations in one patient who ultimately
underwent amputation when stabilized showed that CK
progressively increased after the onset of irretrievable isch-
emia. There may be an early phase of acute ischemia, during
which the ischemic injury is dynamic and perhaps revers-
ible, followed by a progressive and irreversible phase. Such
a hypothesis would require further study.
In a series of patients who had undergone cardiac
surgery, gross increases in CK were noted in some patients,
and a relationship was observed with acute limb ischemia.14
Twelve patients had clinical signs of acute limb ischemia,
and the median CK level was 17,472U/L in this group. By
contrast, the median CK in the remaining patients was
7442 U/L, as compared with 135 U/L in patients under-
going routine elective cardiac surgery. These observations
suggest that CK might be helpful in determining the pres-
ence of severe limb ischemia in sedated, ventilated, cardiac
surgical patients. However, this study clearly set out to
assess the significance of increased CK in cardiac surgical
patients, rather than the significance of increased CK in
patients with acute limb ischemia. Such findings in a highly
specialized patient group should be extrapolated with cau-
tion to the general population with acute limb ischemia.
Other markers of muscle injury as indices of limb
viability after acute ischemia have been investigated in
experimental and clinical studies. In the rabbit, plasma
taurine levels closely correlate with histologic and electron
microscopic evidence of muscle cell death after acute severe
ischemia.15 Conversely, muscle adenosine triphosphate or
lactate content, but not serum myoglobin or carbonic
anhydrase, was strongly predictive of the need for amputa-
tion in patients.16 These tests, which involve chemicalextraction of tissue specimens, are less practical and much
more time consuming than the ubiquitous CK estimation.
If CK had been used to inform clinical decision making
in this study, it is possible that the secondary amputation
rate (38.1%) would have been reduced. Five patients who
underwent secondary amputation had increased CK on
admission. In all five cases, the consultant surgeon had
thought the limbs potentially salvageable. The CK test
strongly suggested that limb loss was overwhelmingly likely
in two patients and more likely than not in the remaining
three. It is noteworthy that these patients formed a substan-
tial subgroup (24%) of those undergoing amputation. If
CK greater than 10 times normal was taken as the threshold
for irreversible ischemia, then at least two patients under-
going amputation as a secondary procedure would have
been prepared for primary amputation alone.
Neutrophilia—but not urea, creatinine, or bicarbonate
levels—was significantly associated with amputation. Pa-
tients with acute limb ischemia often present with acute
comorbidities, such as chest infection or urinary tract infec-
tion. Such infections can precipitate an acute thrombo-
philia due to dehydration and activation of inflammatory
and coagulation cascade mediators and so be a causal factor
in limb ischemia. It was believed that neutrophilia may be
confounded by coexistent disease in limb ischemia and
could not be relied upon as a prognostic marker. With
regard to markers of renal dysfunction, other authors have
shown no relation between creatinine and amputation in a
large retrospective assessment from Sweden.1
In conclusion, this study set out to investigate markers
of irreversible tissue injury in emergency admissions with
acute lower limb ischemia and to assess whether any might
be useful prognostic indicators of limb salvage or major
amputation. The results showed that a history of vascular
surgery, specific clinical signs of ischemia, and increased CK
on admission were significantly associated with major am-
putation. Whereas none of the clinical indicators of isch-
emia had a positive predictive value greater than 50%,
increased CK immediately suggested that amputation was
more likely than limb salvage, whereas normal CK virtually
ensured limb salvage unless secondary events ensued.
Larger multicenter studies of CK in acute limb ischemia are
warranted to further explore this very strong relationship.
The widespread availability of CK estimations and the
objective nature of this test may significantly extend the
prognostic tools available to specialists and nonspecialists
alike who manage acute limb ischemia.
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